Chemoinformaics analysis of
sesquicannabigerol
Molecular Weight | 384.604 | nRot | 12 |
Heavy Atom Molecular Weight | 344.284 | nRig | 9 |
Exact Molecular Weight | 384.303 | nRing | 1 |
Solubility: LogS | -3.937 | nHRing | 0 |
Solubility: LogP | 9.45 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 71.6957 |
nHD | 2 | BPOL | 40.1283 |
QED | 0.285 |
Synth | 2.863 |
Natural Product Likeliness | 1.656 |
NR-PPAR-gamma | 0.942 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.782 |
Pgp-sub | 0.002 |
HIA | 0.006 |
CACO-2 | -4.817 |
MDCK | 0.0000177 |
BBB | 0.128 |
PPB | 0.976079 |
VDSS | 11.172 |
FU | 0.0355637 |
CYP1A2-inh | 0.776 |
CYP1A2-sub | 0.165 |
CYP2c19-inh | 0.767 |
CYP2c19-sub | 0.103 |
CYP2c9-inh | 0.549 |
CYP2c9-sub | 0.98 |
CYP2d6-inh | 0.818 |
CYP2d6-sub | 0.31 |
CYP3a4-inh | 0.382 |
CYP3a4-sub | 0.121 |
CL | 10.908 |
T12 | 0.084 |
hERG | 0.072 |
Ames | 0.006 |
ROA | 0.017 |
SkinSen | 0.949 |
Carcinogencity | 0.081 |
EI | 0.732 |
Respiratory | 0.046 |
NR-Aromatase | 0.734 |
Antiviral | No |
Prediction | 0.545008 |